Skip to main content

One Batch of Insulin Glargine Injection by Mylan Pharmaceuticals

Apr 14, 2022

Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), Due to the Potential for a Missing Label in the Batch

More on the FDA website.